Noah Syndergaard has discomfort in his right elbow

Justin K. Aller/Getty Images
12 Comments

Mets right-hander Noah Syndergaard left after allowing three runs over six innings in Wednesday afternoon’s win against the Royals. Unfortunately, he felt discomfort in his right elbow and will have it examined by a doctor, MLB.com’s Anthony DiComo reports.

Could be nothing, could be something. Lots of consternation until a diagnosis is reached for the Mets, who have received their fair share of bad news lately. Outfielder Yoenis Cespedes left Wednesday’s game due to wrist discomfort. Bartolo Colon faced only one batter during Tuesday’s start because he took a comebacker off of his wrist. Zack Wheeler suffered a setback in his rehab from Tommy John surgery. David Wright is gone for the season due to a herniated disk in his neck, which needs surgery.

Syndergaard improved to 8-2 and now has a 2.08 ERA with a 110/12 K/BB ratio in 91 innings this season. It goes without saying that losing him for any amount of time would be a crushing blow to the defending National League champs.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.